| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |